Latest News

 Filter by Provider

Document technology company Xerox (NASDAQ:XRX) fell short of the markets revenue expectations in Q4 CY2025, but sales rose 25.7% year on year to $2.03 billion. The company’s full-year revenue guidance of $7.5 billion at the midpoint came in 5.1% below analysts’ estimates. Its non-GAAP loss of $0.10 per share was significantly below analysts’ consensus estimates.

Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026.

Honeywell reported mixed Q4 2025 results, with adjusted EPS of $2.59, beating estimates of $2.54. Revenue rose 6% to $9.76B,.

The Dow managed to restore strength after U.S. President Donald Trump abandoned his tariff threat against Europe, easing trade-war concerns.

Cruise vacation company Royal Caribbean (NYSE:RCL) met Wall Streets revenue expectations in Q4 CY2025, with sales up 13.3% year on year to $4.26 billion. Its non-GAAP profit of $2.80 per share was in line with analysts’ consensus estimates.

If you like dividend stocks, here's a high yielder, a Dividend King, and a turnaround story to consider as January comes to a close.

It's hard not to view Rigetti's rise as a flash in the pan.

Financial advisory firm Lazard (NYSE:LAZ) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 14.4% year on year to $929.4 million. Its non-GAAP profit of $0.80 per share was 16.2% above analysts’ consensus estimates.

This property services firm delivers management and restoration solutions to residential and commercial clients across North America.

This medical technology company supplies single-use devices for critical care and surgery to hospitals and healthcare providers worldwide.

The GBP/USD forecast remains tilted to the upside, aiming for 1.3925 as the dollar loses further after the FOMC meeting.

Financial services company Ameriprise Financial (NYSE:AMP) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 11.1% year on year to $4.96 billion. Its non-GAAP profit of $10.83 per share was 5% above analysts’ consensus estimates.